Propenylamide and propenylsulfonamide cephalosporins as a novel class of anti-MRSA β-lactams
✍ Scribed by Jens Pohlmann; Natalya I. Vasilevich; Andrei I. Glushkov; Laurenz Kellenberger; Stuart Shapiro; Patrick Caspers; Malcolm G.P. Page; Franck Danel
- Book ID
- 104004486
- Publisher
- Elsevier Science
- Year
- 2010
- Tongue
- English
- Weight
- 419 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0960-894X
No coin nor oath required. For personal study only.
✦ Synopsis
Novel C(3) propenylamide and propenylsulfonamide cephalosporins have been synthesized and tested for their ability to inhibit the penicillin-binding protein 2' (PBP2') from Staphylococcus epidermidis and the growth of a panel of clinically relevant bacterial species, including methicillin-resistant Staphylococcus aureus (MRSA). The most potent compounds inhibited the growth of MRSA strains with minimum inhibitory concentrations (MIC) as low as 1 microg/mL. The structure-activity relationship revealed the potential for further optimization of this new cephalosporin class.
📜 SIMILAR VOLUMES
## Abstract For Abstract see ChemInform Abstract in Full Text.